-
GenEditBio Secures Strategic Investment from Gobi Partners GBA to Accelerate Breakthrough Genome Editing Technologies
[Hong Kong, September 30th, 2024] – GenEditBio Limited (“GenEditBio”), a biotech company co-founded by Prof. ZHENG Zongli from the City University of Hong Kong that focuses on precision genome editing to provide affordable “precision DNA surgery” for genetic diseases with unmet needs, is pleased to have AEF Greater Bay Area Fund, managed by Gobi Partners GBA, a leading venture capital firm in Asia, invested in our company.
넶0 2024-09-30 -
Dr Zongli ZHENG Participated in Panel Discussion on Venture Fund Support to Start-ups at Asia Summit on Global Health 2024
[May 17, 2024] – GenEditBio Limited (“GenEditBio”), a biotech company focuses on precision genome editing to provide affordable “precision DNA surgery” for genetic diseases with unmet needs, is pleased to announce the participation of our Co-Founder and Chairman, Zongli ZHENG, PhD, as an invited guest speaker on a panel discussion on venture fund support to start-ups at the Asia Summit on Global Health (ASGH) on May 17, 2024, Hong Kong, China.
넶191 2024-05-17 -
GenEditBio to Present New Pre-Clinical Data for its Genome Editing and Delivery Platforms at the 27th Annual Meeting of the American Society of Gene and Cell Therapy
GenEditBio Limited (“GenEditBio”), a biotechnology start-up company focusing on genome-editing therapeutic solutions through the discovery of novel Cas nuclease and the development of safe and efficient cargo delivery platforms, today announced that the Company will have three poster presentations of pre-clinical data across platforms at the upcoming 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) to take place in Baltimore, Maryland, USA, May 8-11, 2024.
넶173 2024-04-30 -
引正基因完成新一轮融资,专注下一代基因编辑工具
2024年4月4日,基因编辑平台型技术企业引正基因科技有限公司(下称“引正基因”,GenEditBio)宣布完成千万美元的Pre-A+轮融资。
넶659 2024-04-04 -
Dr ZHU Tian Participated in Panel Discussion on Healthtech Innovations at Hong Kong Pavilion during 2024
Our Co-Founder and CEO, Dr. ZHU Tian, recently joined a landmark delegation led by the Innovation, Technology and Industry Bureau of the Hong Kong SAR Government to the Middle East. Dr. ZHU also participated in a panel discussion on “Hong Kong Healthtech Innovations Drive G Transformation for Generations to Come” at the Hong Kong Pavilion LEAP 2024 in Riyadh, Saudi Arabia on 4 March 2024.
넶157 2024-03-06